Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renal Research Institute (RRI) is a kidney-focused healthcare research and innovation organization headquartered in New York and operating as a wholly owned subsidiary of Fresenius Medical Care. The organization conducts translational and clinical research aimed at improving outcomes for patients with chronic kidney disease and dialysis-dependent kidney failure, with strengths in data analytics, computational biomedicine, artificial intelligence, laboratory science, and real-world evidence generation. RRI is not a traditional therapeutics biotech with a disclosed drug pipeline; instead, it functions as a research, education, and innovation hub supporting kidney-care advances, dialysis technologies, biomarker research, and AI-enabled clinical tools. Its work spans hemodialysis, hemodiafiltration, fluid management, anemia management, home dialysis utilization, and related nephrology topics, leveraging one of the largest renal datasets available through Fresenius Medical Care and affiliated networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renal Research Institute.